Pulmonary arterial hypertension (PAH) is a type of high blood pressure in the lungs, in which blood vessels are narrowed, blocked or destroyed, causing the heart to work harder and, in time, result in cardiac weakness and ...
May 6, 2022
0
106
The various manifestations of head and neck carcinomas rank sixth in frequency worldwide and are fatal for about half a million people every year. In a quarter of cases, head and neck squamous cell carcinoma (HNSCC) is caused ...
Apr 19, 2022
0
17
Rice University researchers have introduced an online portal to help researchers screen COVID-19 drug candidates that might attack specific proteins of the SARS-CoV-2 virus.
Nov 1, 2021
0
3
In cancer research, it's a common goal to find something about cancer cells—some sort of molecule—that drives their ability to survive, and determine if that molecule could be inhibited with a drug, halting tumor growth. ...
Jul 2, 2021
0
20
New research identified a novel interaction between the SARS-CoV-2 spike protein and the galectin-3-binding protein (LGALS3BP) which could be a new therapeutic anti-viral target. The research also found the presence of detectable ...
Jun 7, 2021
0
14
According to the Global Burden of Disease Study 2017, close to nine percent of the global population lives with some form of chronic kidney disease, or CKD. Not only does the condition affect renal function, but CKD has long ...
Jun 4, 2021
0
13
In cancer immunotherapy, cells in the patient's own immune system are activated to attack cancer cells. CAR T cell therapy has been one of the most significant recent advances in immunotherapies targeted at cancer.
Mar 18, 2021
0
42
More and more evidence is coming out that people with COVID-19 are suffering from cognitive effects, such as brain fog and fatigue.
Dec 17, 2020
2
1831
An antibody first identified in a blood sample from a patient who recovered from Severe Acute Respiratory Syndrome in 2003 inhibits related coronaviruses, including the cause of COVID-19.
May 18, 2020
3
3425
As the world anxiously awaits a remedy for the novel coronavirus, ETH Zurich is also involved in the search for active substances and vaccines. This overview sets out the therapeutic approaches pursued by ETH researchers.
Apr 21, 2020
0
1
